Philosophy For Our Times Will psychedelics revolutionize mental health treatment? | Matthew Johnson, Shayla Love, and Kevin Sabet
35 snips
Aug 29, 2025 
Join Matthew Johnson, a celebrated psychiatry professor at Johns Hopkins, Shayla Love, a keen freelance science reporter, and Kevin Sabet, a drug policy expert, as they dive into the psychedelic renaissance. They explore whether substances like LSD and psilocybin can truly revolutionize mental health treatment. The discussion highlights the importance of subjective experiences over mere biochemistry, the risks of commercialization, and systemic inequities in mental health care access. Can psychedelics fulfill their promise, or is the hype too great?
AI Snips
Chapters
Transcript
Episode notes
Access Determines The Revolution
- Shayla Love says access—not the drug itself—will determine whether psychedelics revolutionize mental healthcare.
- She highlights existing systemic inequities that will shape who benefits from psychedelic therapy.
Follow Rigorous Preparation And Integration
- Prepare, screen and monitor patients carefully during psychedelic sessions to manage risks.
- Provide integration sessions after the acute experience to help translate insights into lasting change.
Experience And Biology Are Intertwined
- The therapy mixes drug-induced brain change with a powerful subjective experience that produces lasting effects.
- Johnson argues both biological and experiential components are essential and intertwined.